{"id":"https://openalex.org/W4399700447","doi":"https://doi.org/10.1016/j.jval.2024.03.233","title":"CO146 Treatment Use and Overall Survival of Patients with Unresectable/Metastatic Melanoma in Colombia: A Real World Study","display_name":"CO146 Treatment Use and Overall Survival of Patients with Unresectable/Metastatic Melanoma in Colombia: A Real World Study","publication_year":2024,"publication_date":"2024-06-01","ids":{"openalex":"https://openalex.org/W4399700447","doi":"https://doi.org/10.1016/j.jval.2024.03.233"},"language":"en","primary_location":{"id":"doi:10.1016/j.jval.2024.03.233","doi":"https://doi.org/10.1016/j.jval.2024.03.233","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2024.03.233","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.jval.2024.03.233","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006384553","display_name":"Sanchez JM Reyes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sanchez JM. Reyes","raw_affiliation_strings":["Pfizer SAS, Bogota, CUN, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer SAS, Bogota, CUN, Colombia","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5099138883","display_name":"J. Bola\u00f1os-L\u00f3pez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J.. Bola\u00f1os-L\u00f3pez","raw_affiliation_strings":["Centro de Biociencias Sura, Medell\u00edn, Antioquia, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Biociencias Sura, Medell\u00edn, Antioquia, Colombia","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"C. Bello","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Bello","raw_affiliation_strings":["Centro de Biociencias Sura, Medell\u00edn, Antioquia, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Biociencias Sura, Medell\u00edn, Antioquia, Colombia","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"AC. Rubio","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"AC. Rubio","raw_affiliation_strings":["Pfizer SAS, Bogot\u00e1, CUN, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer SAS, Bogot\u00e1, CUN, Colombia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073932699","display_name":"Frank J. Gonzalez","orcid":"https://orcid.org/0000-0002-7990-2140","observed_orcids":["https://orcid.org/0000-0002-7990-2140"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"FJ. Gonzalez","raw_affiliation_strings":["Centro de Biociencias Sura, Medell\u00edn, Antioquia, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Biociencias Sura, Medell\u00edn, Antioquia, Colombia","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"A. Toro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Toro","raw_affiliation_strings":["Centro de Biociencias Sura, Medell\u00edn, Antioquia, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Biociencias Sura, Medell\u00edn, Antioquia, Colombia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010362282","display_name":"K. Chen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Chen","raw_affiliation_strings":["Acaster Lloyd Consulting Ltd., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acaster Lloyd Consulting Ltd., Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Arciniegas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Arciniegas","raw_affiliation_strings":["Pfizer SAS, Bogot\u00e1, CUN, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer SAS, Bogot\u00e1, CUN, Colombia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109217394","display_name":"Brigitte Alejandra Alarcon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B.A.. Alarcon","raw_affiliation_strings":["Pfizer SAS, Bogot\u00e1, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer SAS, Bogot\u00e1, Colombia","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084967027","display_name":"M Garcia","orcid":"https://orcid.org/0000-0003-2418-541X","observed_orcids":["https://orcid.org/0000-0003-2418-541X"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Garcia","raw_affiliation_strings":["Pfizer SAS, Bogota, CUN, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer SAS, Bogota, CUN, Colombia","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3200,"currency":"USD","value_usd":3200},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"27","issue":"6","first_page":"S44","last_page":"S44"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.9585000276565552,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.9585000276565552,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.014299999922513962,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.012600000016391277,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.8330000042915344},{"id":"https://openalex.org/keywords/unresectable-melanoma","display_name":"unresectable melanoma","score":0.9860000014305115},{"id":"https://openalex.org/keywords/treatment-utilization","display_name":"treatment utilization","score":0.6959999799728394},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":1.0},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.8970000147819519},{"id":"https://openalex.org/keywords/colombia","display_name":"Colombia","score":0.6489999890327454}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7241415977478027},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.670689582824707},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5624368190765381},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.4988110065460205},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.4838751554489136},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43434062600135803},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.11376646161079407}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jval.2024.03.233","doi":"https://doi.org/10.1016/j.jval.2024.03.233","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2024.03.233","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jval.2024.03.233","doi":"https://doi.org/10.1016/j.jval.2024.03.233","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2024.03.233","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4414864802","https://openalex.org/W4405750126","https://openalex.org/W2040756744","https://openalex.org/W2414704098","https://openalex.org/W4399700887","https://openalex.org/W4414865036","https://openalex.org/W2058903153","https://openalex.org/W4412442853","https://openalex.org/W7048430452","https://openalex.org/W4399706265"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2024-06-16T00:00:00"}